US › Healthcare

InfuSystems Holdings Inc (INFU)

US · Healthcare · Medical Devices

$12.48+0.24%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$36.9M

Revenue YoY

+2.6%

Net profit

$3.2M

Profit YoY

+24.3%

EPS

$0.15

EPS estimate

$0.12

Net margin

8.7%

EPS came in at 0.15 against a street estimate of 0.12 — a beat of 25.0%.

Key statistics

Market cap

$242.0M

P/E

30.4

Forward P/E

22.7

P/B

4.09

Book value

$2.97

EPS (TTM)

$0.40

52-week high

$12.97

52-week low

$7.29

50-day MA

$10.94

200-day MA

$9.58

Beta

1.50

Analyst view

Analysts rate InfuSystems Holdings Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $16.83.

Shareholding

Insiders

7.24%

Institutions

84.59%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InfuSystems Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.